Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

4.66
Delayed Data
As of Jul 22
 -0.08 / -1.69%
Today’s Change
3.68
Today|||52-Week Range
20.43
-39.79%
Year-to-Date
No recent news for Nivalis Therapeutics Inc.

Today’s Trading

Previous close4.74
Today’s open4.70
Day’s range4.60 - 4.86
Volume7,018
Average volume (3 months)47,360
Market cap$72.1M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-156.17%
Earnings growth (this year)+10.84%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
MBRXMoleculin Biotech In...+0.09+1.40%
CAPRCapricor Therapeutic...-0.11-2.57%
REPHRecro Pharma Inc-0.12-1.51%
LIFEaTyr Pharma Inc-0.06-2.03%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$0.00
Annual profit (last year)-$22.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs